Avalide First-Line Indication Gets Unanimous Advisory Panel Endorsement
This article was originally published in The Pink Sheet Daily
Executive Summary
Some members of FDA’s Cardio-Renal Advisory Committee suggest indication could extend to moderately hypertensive patients, not just patients with severe disease.